Perolino, Meljean O.
HRN: 23-36-81 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/23/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/23/2023
07/29/2023
IV
50
Q24
Pcap D
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes